| Acne |
No |
| Active Half-Life |
2-3 days |
| Active substance |
Letrozole |
| Also known as |
Letrozol |
| Aromatization |
No |
| Blood pressure |
Can cause a decrease in blood pressure |
| Chemical name |
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile |
| Classification |
Non-steroidal aromatase inhibitor |
| Dosage |
0.5-1 mg throughout 1 to 3 days |
| Dosage (medical) |
2.5 mg daily |
| Dosage (sports) |
Typically 0.5 mg to 2.5 mg daily depending on purpose and cycling needs |
| Effects |
Reduces estrogen levels, increases luteinizing hormone and follicle-stimulating hormone levels |
| Formula |
C17H11N5 |
| Half-life |
2 days |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
Monitoring of liver function tests, lipid profiles, and bone density |
| Main action |
Inhibits the enzyme aromatase, preventing the synthesis of estrogen |
| Raw Material |
Letrozole |
| Side effects |
Hot flashes, joint pain, fatigue, increased risk of osteoporosis, nausea |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Aromatase inhibitor |
| Trade name |
Femara |
| Use in sports |
Used by bodybuilders and athletes to reduce estrogen levels and increase testosterone levels |
| Water Retention |
No |
| Manufacturer |
Sixpex |
| Packing |
30 tabs (2.5 mg/tab) |
